Biogen salue la décision du Québec de rembourser SPINRAZAMC (nusinersen) pour une vaste population de patients atteints d’amyotrophie spinale (AS)
20 déc. 2018 12h19 HE
|
Biogen Canada
MISSISSAUGA, Ontario, 20 déc. 2018 (GLOBE NEWSWIRE) -- Cette décision découle de la recommandation positive de l’Institut national d’excellence en santé et services sociaux (INESSS) qui...
Biogen Applauds Quebec Decision to Cover SPINRAZA™ (nusinersen) for a broad population of SMA Patients
20 déc. 2018 12h19 HE
|
Biogen Canada
The decision follows positive recommendation from the Institut national d'excellence en santé et services sociaux (INESSS) recognising the urgency and need for a treatment for patients with SMA and...
New SPINRAZA® (nusinersen) Data Presented at Annual Congress of the World Muscle Society Demonstrate Benefits in Treating Presymptomatic Infants with Spinal Muscular Atrophy
06 oct. 2018 07h30 HE
|
Biogen Inc.
NURTURE study participants were alive and did not require permanent ventilation, in contrast to natural history of spinal muscular atrophy (SMA)Study participants achieved motor milestones with 100...
Vestmark Announces Innovative Options Trading and Risk Management Capabilities
16 août 2018 09h30 HE
|
Vestmark, Inc.
WAKEFIELD, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Vestmark, the leading provider of portfolio management and trading solutions for financial advisors and institutions, today announced a new...
Spotlight Innovation Spinal Muscular Atrophy Research Collaborator Professor Kevin Hodgetts Receives $300,000 Grant from Cure SMA
24 juil. 2018 08h55 HE
|
Spotlight Innovation Inc.
URBANDALE, IA, July 24, 2018 (GLOBE NEWSWIRE) -- Spotlight Innovation Inc. (OTCQB: STLT), a pharmaceutical company targeting rare, emerging and neglected diseases, today announced that Company...
Cytokinetics Announces Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy Presented at the 2018 Annual Cure SMA Conference
16 juin 2018 11h40 HE
|
Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., June 16, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced data from the Phase 2 clinical study of reldesemtiv in patients with spinal...
Scholar Rock Announces Completion of Dosing of First Cohort in Phase 1 Clinical Trial of SRK-015
31 mai 2018 07h00 HE
|
Scholar Rock
CAMBRIDGE, Mass., May 31, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ:SRRK), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of...
Engage121 Achieves Record First Quarter Growth in Full-Service Managed Social Media Subscriptions
25 avr. 2018 08h00 HE
|
Engage121
NORWALK, CT, April 25, 2018 (GLOBE NEWSWIRE) -- Engage121, a social media communications software and services technology company achieves 100% growth in first quarter over fourth quarter for their...
Engage121 Celebrates 20 Years of Innovation in PR and Social Media Communications Technology
04 avr. 2018 08h30 HE
|
Engage121
Norwalk, Conn., April 04, 2018 (GLOBE NEWSWIRE) --
In 2018, Engage121, a social media communications software and services technology company headquartered in Connecticut, celebrates its...
Factory Automation Market To Rise With Increasing Cost Effective Industrial Applications - IndustryARC Research
23 mars 2017 11h00 HE
|
IndustryARC
Hyderabad, India, March 23, 2017 (GLOBE NEWSWIRE) -- The report “Factory Automation Market: By Electrical Components (Inverters, Touch Panel, Timers, Controllers, Breakers, Switches, Convertors,...